Venus Concept Inc. (NASDAQ:VERO) Sees Large Growth in Short Interest

Venus Concept Inc. (NASDAQ:VERO) saw a significant increase in short interest in the month of February. As of February 28th, there was short interest totalling 25,300 shares, an increase of 4,116.7% from the February 13th total of 600 shares. Approximately 6.7% of the company’s shares are short sold. Based on an average daily volume of 48,700 shares, the short-interest ratio is currently 0.5 days.

Venus Concept Trading Up 6.5 %

NASDAQ:VERO traded up $0.18 during mid-day trading on Wednesday, reaching $2.93. 15,795 shares of the company’s stock traded hands, compared to its average volume of 91,228. Venus Concept has a 12-month low of $2.33 and a 12-month high of $17.49. The company has a debt-to-equity ratio of 2.83, a current ratio of 1.86 and a quick ratio of 1.18. The company has a 50 day moving average price of $3.79 and a 200-day moving average price of $4.50. The firm has a market capitalization of $1.93 million, a price-to-earnings ratio of -0.37 and a beta of 0.52.

About Venus Concept

Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.